Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: A glycopeptide approach

Glycobiology

Volumn 18, Issue 1, 2008, Pages 2-8

  Tajiri, Michiko ^a,b   Ohyama, Chikara ^c   Wada, Yoshinao ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

N glycans; Prostate cancer; Prostate specific antigen (PSA); Sialic acid

Indexed keywords

GLYCAN; GLYCOPEPTIDE; OLIGOSACCHARIDE; PROSTATE SPECIFIC ANTIGEN; SIALIC ACID; SIALIDASE;

ARTHROBACTER; ARTHROBACTER UREAFACIENS; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTROPHORESIS; FUCOSYLATION; GLYCOSYLATION; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL PLASMA; SIALYLATION; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; FUCOSE; GLYCOPEPTIDES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEMEN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

ARTHROBACTER UREAFACIENS; STREPTOCOCCUS PNEUMONIAE;

EID: 37549016762     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwm117     Document Type: Article

References (26)

1. Bélanger A, van Halbeek H, Graves HC, Grandbois K, Stamey TA, Huang L, Poppe I, Labrie F. 1995. Molecular mass and carbohydrate structure of prostate specific antigen: Studies for establishment of an international PSA standard. Prostate. 27:187-197.
2. Catalona WJ, Smith DS, Ornstein DK. 1997. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA. 277:1452-1455.
3. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT et al. 1998. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial. JAMA. 279:1542-1547.
4. Christensson A, Laurell CB, Lilja H. 1990. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem. 194:755-763.
5. Fukuda M. 1996. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 56:2237-2244.
6. Jain S, Bhojwani AG, Mellon JK. 2002. Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: The use of PSA derivatives and novel markers. Postgrad Med J. 78:646-650.
7. Kim YJ, Varki A. 1997. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J. 14:569-576.
8. Laine A, Hachulla E, Strecker G, Michalski JC, Wieruszeski JM. 1991. Structure determination of the glycans of human-serum α1-antichymotrypsin using 1H-NMR spectroscopy and deglycosylation by N-glycanase. Eur J Biochem. 197:209-215.
9. Lilja H, Christensson A, Dahlén U, Matikainen MT, Nilsson O, Pettersson K, Lövgren T. 1991. Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem. 37:1618-1625.
10. Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M. 2004. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy Glycobiology. 14:671-679.
11. Okada T, Sato Y, Kobayashi N, Sumida K, Satomura S, Matsuura S, Takasaki M, Endo T. 2001. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid. Biochim Biophys Acta. 1525:149-160.
12. Peracaula R, Tabarés G, Royle L, Harvey DJ, Dwek RA, Rudd PM, de Llorens R. 2003. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology. 13:457-470.
13. Peter J, Unverzagt C, Hoesel W. 2000. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with -antichymotrypsin (PSA-ACT). Clin Chem. 46:474-482.
14. Prakash S, Robbins PW. 2000. Glycotyping of prostate specific antigen. Glycobiology. 10:173-176.
15. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. 2006. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 1:2856-2860.
16. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. 1987. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:909-916.
17. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. 1991. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay ofthe complex improves clinical sensitivity for cancer. Cancer Res. 51:222-226.
18. Stratikos E, Gettins PG. 1997. Major proteinase movement upon stable serpin-proteinase complex formation. Proc Natl Acad Sci USA. 94:453-458.
19. Sumi S, Arai K, Kitahara S, Yoshida K. 1999. Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar-chain structures of prostate-specific antigen in human prostate carcinoma. J Chromatogr B Biomed Sci Appl. 727:9-14.
20. Tabarés G, Radcliffe CM, Barrabés S, Ramírez M, Aleixandre RN, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R. 2006. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology. 16:132-145.
21. Tabarés G, Jung K, Reiche J, Stephan C, Lein M, Peracaula R, de Llorens R, Hoesel W. 2007. Free PSA forms in prostatic tissue and sera of prostate cancer patients: Analysis by 2-DE and western blotting of immunopurified samples. Clin Biochem. 40:343-350.
22. Tajiri M, Yoshida S, Wada Y. 2005. Differential analysis of site-specific glycans on plasma and cellular fibronectins: Application of a hydrophilic affinity method for glycopeptide enrichment, Glycobiology. 15:1332-1340.
23. van Halbeek H, Gerwig GJ, Vliegenthart JF, Tsuda R, Hara M, Akiyama K, Schmid K. 1985. Occurrence of the Y determinant on the N glycosidic carbohydrate units of human gamma-seminoprotein. Biochem Biophys Res Commun. 131:507-514.
24. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J et al. 2006. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 116:271-284.
25. Wada Y, Tajiri M, Yoshida S. 2004. Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal Chem. 76:6560-6565.
26. Wada Y, Azadi P, Costello CE, Dell A, Dwek RA, Geyer H, Geyer R, Kakehi K, Karlsson NG, Kato K et al. 2007. Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology., 17:411-422.